Genetic background selectively influences innominate artery atherosclerosis: Immune system deficiency as a probe

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 8, 2003, Pages 1449-1454

  Reardon, Catherine A ^a   Blachowicz, Lydia ^b   Lukens, John ^b   Nissenbaum, Michael ^b   Getz, Godfrey S ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

Aortic sinus; Atherosclerosis; Genetics; Innominate artery; LDL receptor deficiency

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR; RAG1 PROTEIN; RAG2 PROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SINUS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; B LYMPHOCYTE; BACKCROSSING; BRACHIOCEPHALIC TRUNK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; HEREDITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; LIPID BLOOD LEVEL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANIMALS; ARTERIOSCLEROSIS; B-LYMPHOCYTES; BRACHIOCEPHALIC TRUNK; CHOLESTEROL, VLDL; DNA-BINDING PROTEINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; T-LYMPHOCYTES;

EID: 0041733067     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000079793.58054.2E     Document Type: Article

References (35)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Reardon CA, Blachowicz L, White T, Cabana V, Wang Y, Lukens J, Bluestone J, Getz GS. Effect of immune deficiency on lipoproteins and atherosclerosis in male apoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2001;21:1011-1016.
3. Daugherty A, Pure E, Delfel-Butteiger D, Chen S, Leferovich J, Roselaar SE, Rader DJ. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J Clin Invest. 1997;100:1575-1580.
4. Dansky HM, Charlton SA, Harper MM, Smith JD. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1997;94:4642-4646.
5. Song L, Leung C, Schindler C. Lymphocytes are important in early atherosclerosis. J Clin Invest. 2001;108:251-259.
6. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. IFN-γ potentiates atherosclerosis in apoE knock-out mice. J Clin Invest. 1997;99:2752-2761.
7. Whitman SC, Ravisankar P, Daugherty A. IFN-γ deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. J Interferon Cytokine Res. 2002;22:661-670.
8. Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, Humbert Y, Chvatchko Y, Tedgui A. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res. 2001;89:e41-e45.
9. Whitman SC, Ravisankar P, Daugherty A. Interluekin-18 enhances atherosclerosis in apolipoprotein E-/- mice through release of interferon-γ. Circ Res. 2002;90:e34-e38.
10. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest. 2002;109:745-753.
11. Major A, Fazio S, Linton MF. B lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol. 2002;22:1892-1898.
12. Freigang S, Hörkkö S, Miller E, Witztum JL, Palinski W. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol. 1998;18:1972-1982.
13. Shinkai Y, Rathbun G, Lam K-P, Oitz EM, Stewart V, Mendelsohn M, Charron JL, Datta M, Young F, Stall AM, Alt FW. RAG-2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 1992;68:855-867.
14. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature T and B lymphocytes. Cell. 1992;68:869-877.
15. Nicoletti A, Kaveri S, Caligiuri G, Bariety J, Hansson GK. Immunoglobulin treatment reduces atherosclerosis in apoE knockout mice. J Clin Invest. 1998;102:910-918.
16. Grawunder U, Harfst E. How to make ends meet in V(D)J recombination. Curr Opin Immunol. 2001;13:186-194.
17. Witting PK, Pettersson K, Letters J, Stocker R. Site-specific antiatherogenic effect of probucol in apolipoprotein E- deficient mice. Arterioscler Thromb Vasc Biol. 2000;20:e26-e33.
18. Methia N, Andre P, Denis CV, Economopoulos M, Wagner DD. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood. 2001;98:1424-1428.
19. King VL, Szilvassy SJ, Daugherty A. IL-4 deficiency decreases atherosclerosis formation in female LDL receptor deficient mice. Arterioscler Thromb Vasc Biol. 2002;22:456-461.
20. Mehrabian M, Allayee H, Wong J, Shih W, Wang X-P, Shaposhnik Z, Funk CD, Lusis AJ. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res. 2002;91:120-126.
21. Welch CL, Bretschger S, Latib N, Bezouevski M, Guo Y, Pleskac N, Liang C-P, Barlow C, Dansky H, Breslow JL, Tall AR. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc Natl Acad Sci U S A. 2001;98:7946-7951.
22. Dansky HM, Shu P, Donavan M, Montagno J, Nagel DL, Smutko JS. Roy N, Whiteing S, Barrios J, McBride TJ, Smith JD, Duyk G, Breslow JL, Moore KJ. A phenotype-sensitizing apoE-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. Genetics. 2002;160:1599-1608.
23. Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, Levin LP, Shu P, Moore KJ, Breslow JL, Smith JD. Genetic background determines the extent of atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vasc Biol. 1999;19:1960-1968.
24. Smith JD, Dansky HM, Breslow JL. Genetic modifiers of atherosclerosis in mice. Ann N Y Acad Sci. 2001;947:247-253.
25. Mehrabian M, Wong J, Wang X, Jiang Z, Shi W, Fogelman AM, Lusis AJ. Genetic loci in mice that block the development of atherosclerosis despite extreme hyperlipidemia. Circ Res. 2001;89:125-130.
26. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med. 1988;112:1018-10311.
27. Giddens DP, Zarins CK, Glagov S. The role of fluid mechanics in the localization and detection of atherosclerosis. J Biomech Eng. 1993;115:588-594.
28. Garcia-Cardena G, Comander J, Anderson KR, Blackman BR, Gimbrone MA. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci USA. 2001;98:4478-4485.
29. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell. 2001;104:503-516.
30. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
31. Reardon CA, Getz GS. Mouse models of atherosclerosis. Curr Opin Lipidol. 2001;12:167-173.
32. Whitman SC, Ravisankar P, Elam H, Daugherty A. Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol. 2000;157:1819-1824.
33. Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, Curtiss LK, Berliner JA, Boisvert WA. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res. 2002;90:1064-1071.
34. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ Res. 1999;85:e17-e24.
35. Zhou X, Paulsson G, Stemme S, Hansson GK. Hypercholesterolemia is associated with a T helper (Th)1/Th2 switch of the autoimmune response in atherosclerotic apoE-knockout mice. J Clin Invest. 1998;101:1717-1725.